A significant discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in various types of tumors, https://bookmarkahref.com/story21936081/vhh-fragments-reactivate-p53-new-potential-pathway-for-tumor-therapy